Dysfunctional immunoregulation in human liver allograft rejection associated with compromised galectin-1/CD7 pathway...

Area of Science:

• Immunology
• Transplantation Biology
• Cellular and Molecular Medicine

Background:

• Regulatory T cells (Tregs) are crucial for immune tolerance after organ transplantation.
• Dysfunctional Tregs in liver allograft rejection patients fail to control responder T cells.
• Galectin-1 (Gal1) binding to CD7 on responder T cells is a known inhibitory mechanism.

Purpose of the Study:

• To investigate if reduced Galectin-1 (Gal1) expression in regulatory T cells (Tregs) and/or reduced CD7 expression on responder T cells contribute to immune dysfunction in liver allograft rejection.
• To assess the impact of Gal1 and CD7 expression levels on Treg suppressive function in transplant patients.

Main Methods:

• Profiling of circulating Tregs and responder T cells from acute rejection patients, patients in remission, and healthy controls.
• Co-culture assays to evaluate Treg suppressor function on CD7+ and CD7- responder T cells.
• Gal1 gene silencing using small interfering RNA (siRNA) in Tregs.
• Flow cytometry analysis of CD7, CD43, and CD45 expression on T cells.

Main Results:

• Lower proportions of CD7+ responder T cells and Gal1+ Tregs were observed in acute rejection patients compared to controls and patients in remission.
• Reduced Gal1 expression in Tregs impaired their ability to suppress CD7+ responder T cells.
• Downregulation of CD43 on responder T cells in acute rejection patients further reduced their susceptibility to Treg-mediated suppression.

Conclusions:

• Reduced Galectin-1 (Gal1) expression in regulatory T cells and decreased CD7 expression on responder T cells are key factors in the dysfunctional immunoregulation seen in liver allograft rejection.
• Responder T-cell CD43 downregulation in acute rejection patients exacerbates the impaired immune control by reducing responsiveness to regulatory T cells.